Zeitschriften der Strahlentherapie

Publikationen

Publikationen der AG Onkologische Versorgungsforschung

Stand: 29.1.2024

  1. Hassan L, Bedir A, Kraus FB, Ostheimer C, Vordermark D, Mikolajczyk R, Seliger B, Medenwald D. Correlation of Increased Soluble Tumor Necrosis Factor Receptor 1 with Mortality and Dependence on Treatment in Non-Small-Cell Lung Cancer Patients: A Longitudinal Cohort Study. Cancers 2024, 16, 525. doi: 10.3390/cancers16030525.

  2. Müller JA, Kluttig A, Medenwald D. Leitlinienassoziierte Versorgungsforschung in der Onkologie unter Nutzung von Registerdaten. Forum (2023). doi: 10.1007/s12312-023-01263-z

  3. Müller JA, Delank KS, Laudner K, Wittenberg I, Zeh A, Vordermark D, Medenwald D. Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry. J Cancer Res Clin Oncol. 2023 Sep 26. doi: 10.1007/s00432-023-05350-5. Epub ahead of print. PMID: 37750956.

  4. Bedir A, Mehrotra S, Gnüchtel J, Vordermark D, Medenwald D. Treatment patterns in stage III non‑small‑cell lung cancer patients: a population‑based study using German cancer registry data. J Cancer Res Clin Oncol. 2023 Aug 30. doi: 10.1007/s00432-023-05289-7. Epub ahead of print. PMID: 37648808.

  5. Beutner K, Medenwald D, Meyer G. Sektorenübergreifende Versorgungsverläufe von Patient*innen mit kolorektalem Karzinom in Sachsen-Anhalt [Cross-sectoral care trajectories of patients with colorectal cancer in Saxony-Anhalt]. Gesundheitswesen. 2023 Aug 10. German. doi: 10.1055/a-2106-9644. Epub ahead of print. PMID: 37562409.

  6. Bache M, Kadler F, Struck O, Medenwald D, Ostheimer C, Güttler A, Keßler J, Kappler M, Riemann A, Thews O, Seliger B, Vordermark D. Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients. Int J Mol Sci. 2023 Aug 16;24(16):12835. doi: 10.3390/ijms241612835. PMID: 37629015; PMCID: PMC10454434.

  7. Jacob J, Vordermark D, Lorenz K, Medenwald D. Prognostic factors in radiotherapy of anaplastic thyroid carcinoma: a single center study over 31 years. Radiat Oncol18, 71 (2023). doi: 10.1186/s13014-023-02249-w

  8. Kassik MT, Vordermark D, Kornhuber C, Medenwald D. Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting. Radiat Oncol18, 70 (2023). doi: 10.1186/s13014-023-02252-1

  9. Müller JA, Vordermark D, Medenwald D. Mortality after radiotherapy or surgery in the treatment of early-stage non-small-cell lung cancer: a population-based data analysis in the clinical cancer registry of Brandenburg-Berlin. Strahlenther Onkol. 2023 Mar 13. doi: 10.1007/s00066-023-02055-z. Epub ahead of print. PMID: 36912978.

  10. Müller JA, Trommer S, Meyer F, Lampe K, Croner RS, Vordermark D, Medenwald D. Was muss der Allgemein- und Viszeralchirurg von der onkologisch ausgerichteten Strahlentherapie wissen? [What does the general and abdominal surgeon need to know about oncologically oriented radiotherapy?]. Chirurgie (Heidelb). 2023 Mar 9. German. doi: 10.1007/s00104-023-01820-1. Epub ahead of print. PMID: 36892602.

  11. Gnüchtel J, Vordermark D, Medenwald D. Survey of treatment and care practices in small-cell lung cancer among German radiation oncologists. Strahlenther Onkol. 2022 Nov 23. doi: 10.1007/s00066-022-02019-9. Epub ahead of print. PMID: 36418442.

  12. Abera SF, Bedir A, Glowka A, Vordermark D, Medenwald D. Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data. BMC Cancer. 2022 Jun 7;22(1):624. doi: 10.1186/s12885-022-09677-z. PMID: 35672732; PMCID: PMC9171996.

  13. Bedir A, Abera SF, Vordermark D, Medenwald D. Socioeconomic disparities in endometrial cancer survival in Germany: a survival analysis using population-based cancer registry data. J Cancer Res Clin Oncol. 2022 Jan 22. doi: 10.1007/s00432-021-03908-9. Online ahead of print. PMID: 35064816

  14. Mäurer M, Käsmann L, Fleischmann DF, Oertel M, Jazmati D, Medenwald D; Young DEGRO Trial Group. PET/CT-based adaptive radiotherapy of locally advanced non-small cell lung cancer in multicenter yDEGRO ARO 2017-01 cohort study. Radiat Oncol. 2022 Feb 9;17(1):29. doi: 10.1186/s13014-022-01997-5. PMID: 35139856; PMCID: PMC8827193.

  15. Werner C, Stangl S, Salvermoser L, Schwab M, Shevtsov M, Xanthopoulos A, Wang F, Dezfouli AB, Thölke D, Ostheimer C, Medenwald D, Windberg M, Bache M, Schlapschy M, Skerra A, Multhoff G. Hsp70 in Liquid Biopsies-A Tumor-Specific Biomarker for Detection and Response Monitoring in Cancer. Cancers (Basel). 2021 Jul 23;13(15):3706. doi: 10.3390/cancers13153706. PMID: 34359606; PMCID: PMC8345117.

  16. Medenwald D, Fietkau R, Klautke G, Langer S, Würschmidt F, Vordermark D. Trends in radiotherapy inpatient admissions in Germany: a population-based study over a 10-year period. Strahlenther Onkol. 2021 Oct;197(10):865-875. doi: 10.1007/s00066-021-01829-7. Epub 2021 Sep 3. PMID: 34477888; PMCID: PMC8458212.

  17. Medenwald D, Brunner T, Christiansen H, Kisser U, Mansoorian S, Vordermark D, Prokosch HU, Seuchter SA, Kapsner LA; our MII research group. Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient data. Strahlenther Onkol. 2022 Jan 7:1–12. doi: 10.1007/s00066-021-01883-1. Epub ahead of print. PMID: 34994804; PMCID: PMC8739685.

  18. Dapper H, Belka C, Bock F, Budach V, Budach W, Christiansen H, Debus J, Distel L, Dunst J, Eckert F, Eich H, Eicheler W, Engenhart-Cabillic R, Fietkau R, Fleischmann DF, Frerker B, Giordano FA, Grosu AL, Herfarth K, Hildebrandt G, Kaul D, Kölbl O, Krause M, Krug D, Martin D, Matuschek C, Medenwald D, Nicolay NH, Niewald M, Oertel M, Petersen C, Pohl F, Raabe A, Rödel C, Rübe C, Schmalz C, Schmeel LC, Steinmann D, Stüben G, Thamm R, Vordermark D, Vorwerk H, Wiegel T, Zips D, Combs SE. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlenther Onkol. 2022 Jan;198(1):1-11. doi: 10.1007/s00066-021-01861-7. Epub 2021 Nov 16. PMID: 34786605; PMCID: PMC8594460.

  19. Efremov L, Abera SF, Bedir A, Vordermark D, Medenwald D. Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries. J Cancer Res Clin Oncol. 2021 Nov;147(11):3381-3390. doi: 10.1007/s00432-021-03596-5. Epub 2021 Mar 20. Erratum in: J Cancer Res Clin Oncol. 2021 Apr 13;: PMID: 33743072; PMCID: PMC8484256.

  20. Seraphin TP, Joko-Fru WY, Hämmerl L, Griesel M, Mezger NCS, Feuchtner JC, Adoubi I, Egué MD, Okerosi N, Wabinga H, Hansen R, Vuma S, Lorenzoni C, Coulibaly B, Odzebe SW, Buziba NG, Aynalem A, Liu B, Medenwald D, Mikolajczyk RT, Efstathiou JA, Parkin DM, Jemal A, Kantelhardt EJ. Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 2021 Nov 15;127(22):4221-4232. doi: 10.1002/cncr.33818. Epub 2021 Jul 30. PMID: 34328216.

  21. Medenwald D, Brunner T, Christiansen H, Kisser U, Mansoorian S, Vordermark D, Prokosch HU, Seuchter SA, Kapsner LA; our MII research group. Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient data. Strahlenther Onkol. 2022 Jan 7:1–12. doi: 10.1007/s00066-021-01883-1. Epub ahead of print. PMID: 34994804; PMCID: PMC8739685.

  22. Medenwald D, Schmidt-Pokrzywniak A, Kapsner LA, Buttmann-Schweiger N, Hopff S, Schmidt H, Vordermark D. Onkologische Versorgungsforschung in Deutschland - Neue Perspektiven durch Vernetzung. Forum (2021). doi: 10.1007/s12312-021-00996-z.

  23. Medenwald D, Fietkau R, Klautke G, Langer S, Würschmidt F, Vordermark D. Trends in radiotherapy inpatient admissions in Germany: a population-based study over a 10-year period. Strahlenther Onkol. 2021 Sep 3. doi: 10.1007/s00066-021-01829-7. Epub ahead of print. PMID: 34477888.

  24. Flöther L, Pötzsch B, Jung M, Jung R, Bucher M, Glowka A, Medenwald D. Treatment effects of palliative care consultation and patient contentment: A monocentric observational study. Medicine (Baltimore) 2021 Mar 26;100(12):e24320. doi:10.1097/MD.0000000000024320. PMID: 33761631.
  25. Abera S, Mikolajczyk R, Kantelhardt E, Efremov L, Bedir A, Ostheimer C, Glowka A, Vordermark D, Medenwald D. Lung Cancer Attributed Mortality Among 316,336 Early Stage Breast Cancer Cases Treated by Radiotherapy and/or Chemotherapy, 2000-2015: Evidence From the SEER Database. Front Oncol. 2021 Feb 25;10:602397. doi: 10.3389/fonc.2020.602397. eCollection 2020. PMID: 33718108.
  26. Efromov L, Abera S, Bedir A, Vordermark D, Medenwald D. Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from rhe German Cancer Registries. J Cancer Res Clin Oncol. 2021 Mar 20. doi: 10.1007/s00432-021-03596-5. PMID: 33743072.
  27. Bedir A, Abera SF, Efremov L, Hassan L, Vordermark D, Medenwald D. Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data. J Cancer Res Clin Oncol. 2021 Feb 11.
  28. C. Ostheimer MD, M. Mäurer, […] D. Medenwald. Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group. Strahlenther Onkol (2021). https://doi.org/10.1007/s00066-020-01727-4.
  29. Kraus FB, Medenwald D, Ludwig-Kraus B(2020) Do extreme summers increase blood vitaminD (25-hydroxyvitaminD) levels? PLoSONE 15(11):e0242230. https://doi.org/10.1371/journal.pone.0242230.
  30. Abera Ferede S, Mikolajczyk RT, Kantelhardt E, Efremov L, Bedir A,  Ostheimer C, Glowka A, Vordermark D and Medenwald D (2020) Lung Cancer Attributed Mortality Among 316,336 Early Stage Breast Cancer Cases Treated by Radiotherapy and/or Chemotherapy, 2000–2015: Evidence From the SEER Database. Front. Oncol. 10:602397.doi: 10.3389/fonc.2020.602397.
  31. Medenwald D, Ferencz J, Vordermark D. Predictors of the regional variation of prostatectomy or radiotherapy: evidence from German cancer registries. J Cancer Res Clin Oncol (2020). https://doi.org/10.1007/s00432-020-03140-x.
  32. Evers C, Ostheimer C, Sieker F, Vordermark D, Medenwald D. Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments. PLoS One. 2020 Feb26;15(2):e0229266. doi: 10.1371/journal.pone.0229266. eCollection 2020. PubMed PMID: 32101560.
  33. Medenwald D, Vordermark D, Dietzel C. Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany. Front. Oncol., 17 January 2020. https://doi.org/10.3389/fonc.2019.01451.
  34. Ostheimer C, Evers C, Palm F, Mikolajczyk R, Vordermark D, Medenwald D. Mortality after radiotherapy or surgery in the treatment of early stage non-small-cell lung cancer: a population-based study on recent developments. J Cancer Res Clin Oncol. 2019 Sep 6. doi:10.1007/s00432-019-03013-y. [Epub ahead of print] PubMed PMID: 31492985.
  35. Medenwald D, Vordermark D, Dietzel CT. Number of radiotherapy treatment machines in the population and cancer mortality: an ecological study. Clin Epidemiol. 2018 Sep 21;10:1249-1273. doi: 10.2147/CLEP.S156764. eCollection 2018. PubMed PMID: 30288122; PubMed Central PMCID: PMC6163015.
  36. Medenwald D, Dietzel CT, Vordermark D. Health services research in German radiation oncology: new opportunities to advance cancer care. Strahlenther Onkol. 2018 Dec;194(12):1097-1102. doi: 10.1007/s00066-018-1357-4. Epub 2018 Sep 4. Review. PubMed PMID: 30182245.
  37. Käsmann L, Niyazi M, Blanck O, Baues C, Baumann R, Dobiasch S, Eze C, Fleischmann D, Gauer T, Giordano FA, Goy Y, Hausmann J, Henkenberens C, Kaul D, Klook L, Krug D, Mäurer M, Panje CM, Rosenbrock J, Sautter L, Schmitt D, Süß C, Thieme AH, Trommer-Nestler M, Ziegler S, Ebert N, Medenwald D, Ostheimer C; Young DEGRO Trial Group. Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review. Strahlenther Onkol. 2018 Feb;194(2):79-90. doi:10.1007/s00066-017-1221-y. Epub 2017 Oct 13. Review. PubMed PMID: 29030654.
  38. Wild PS, Felix JF, Schillert A, Teumer A, Chen MH, Leening MJG, Völker U, Großmann V, Brody JA, Irvin MR, Shah SJ, Pramana S, Lieb W, Schmidt R, Stanton AV, Malzahn D, Smith AV, Sundström J, Minelli C, Ruggiero D, Lyytikäinen LP, Tiller D, Smith JG, Monnereau C, Di Tullio MR, Musani SK, Morrison AC, Pers TH, Morley M, Kleber ME, Aragam J, Benjamin EJ, Bis JC, Bisping E, Broeckel U, Cheng S, Deckers JW, Del Greco M F, Edelmann F, Fornage M, Franke L, Friedrich N, Harris TB, Hofer E, Hofman A, Huang J, Hughes AD, Kähönen M, Investigators K, Kruppa J, Lackner KJ, Lannfelt L, Laskowski R, Launer LJ, Leosdottir M, Lin H, Lindgren CM, Loley C, MacRae CA, Mascalzoni D, Mayet J, Medenwald D, Morris AP, Müller C, Müller-Nurasyid M, Nappo S, Nilsson PM, Nuding S, Nutile T, Peters A, Pfeufer A, Pietzner D, Pramstaller PP, Raitakari OT, Rice KM, Rivadeneira F, Rotter JI, Ruohonen ST, Sacco RL, Samdarshi TE, Schmidt H, Sharp ASP, Shields DC, Sorice R, Sotoodehnia N, Stricker BH, Surendran P, Thom S, Töglhofer AM, Uitterlinden AG, Wachter R, Völzke H, Ziegler A, Münzel T, März W, Cappola TP, Hirschhorn JN, Mitchell GF, Smith NL, Fox ER, Dueker ND, Jaddoe VWV, Melander O, Russ M, Lehtimäki T, Ciullo M, Hicks AA, Lind L, Gudnason V, Pieske B, Barron AJ, Zweiker R, Schunkert H, Ingelsson E, Liu K, Arnett DK, Psaty BM, Blankenberg S, Larson MG, Felix SB, Franco OH, Zeller T, Vasan RS, Dörr M. Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J Clin Invest. 2017 May 1;127(5):1798-1812. doi: 10.1172/JCI84840. Epub 2017 Apr 10. PubMed PMID: 28394258; PubMed Central PMCID: PMC5409098.
  39. Medenwald D, Vordermark D, Dietzel CT. Cancer mortality in former East and West Germany: a story of unification? BMC Cancer. 2017 Feb 2;17(1):94. doi: 10.1186/s12885-017-3086-y. PubMed PMID: 28148231; PubMed Central PMCID: PMC5288858.
  40. Herzog B, Lacruz ME, Haerting J, Hartwig S, Tiller D, Medenwald D, Vogt S, Thorand B, Holle R, Bachlechner U, Boeing H, Merz B, Nöthlings U, Schlesinger S, Schipf S, Ittermann T, Aumann N, Schienkiewitz A, Haftenberger M, Greiser KH, Neamat-Allah J, Katzke V, Kluttig A. Socioeconomic status and anthropometric changes-A meta-analytic approach from seven German cohorts. Obesity (Silver Spring). 2016 Mar;24(3):710-8. doi: 10.1002/oby.21366. Epub 2016 Feb 1. PubMed PMID: 26833586.
  41. Medenwald D, Kuss O. Mortality on match days of the German national soccer team: a time series analysis from 1995 to 2009. J Epidemiol Community Health. 2014 Sep;68(9):869-73. doi: 10.1136/jech-2013-202844. Epub 2014 May 8. PubMed PMID: 24811776.
  42. Medenwald D, Kuss O. Deaths and major biographical events: a study of all cancer deaths in Germany from 1995 to 2009. BMJ Open. 2014 Apr 2;4(4):e004423. doi: 10.1136/bmjopen-2013-004423. PubMed PMID: 24694623; PubMed Central PMCID: PMC3987729.